Literature DB >> 15241624

[Classification of pulmonary alveolar proteinosis in newborns, infants, and children].

F Brasch1, K-M Müller.   

Abstract

Pulmonary alveolar proteinoses are rare pulmonary diseases characterised by an intraalveolar accumulation of surfactant protein A. Subtyping of alveolar proteinoses: Type I alveolar proteinoses: severe respiratory insufficiency in newborns, which will take a lethal course without lung transplant; hereditary SP-B deficiency and an intraalveolar accumulation of N-terminal incompletely processed SP-C. Type II alveolar proteinoses: occur in newborns and infants; often take a lethal course; show intraalveolar accumulation of precursors of SP-B and mature SP-B as well as an accompanying interstitial lung disease of variable severity. Type III alveolar proteinoses: in infants and children; do not generally take a lethal course; they are characterised by an intraalveolar accumulation of precursors of SP-B and mature SP-B without accompanying interstitial lung disease. "Cryptogenic" congenital, acquired (idiopathic), and secondary type III alveolar proteinoses can be distinguished. In newborns, infants, and children with pulmonary alveolar proteinosis, a detailed pathological-anatomical examination including immunohistochemical and molecular genetic analyses, should be performed in order to optimise the therapeutical management.

Entities:  

Mesh:

Year:  2004        PMID: 15241624     DOI: 10.1007/s00292-004-0706-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  37 in total

1.  A mutation in the surfactant protein C gene associated with familial interstitial lung disease.

Authors:  L M Nogee; A E Dunbar; S E Wert; F Askin; A Hamvas; J A Whitsett
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

2.  Lung transplantation for treatment of infants with surfactant protein B deficiency.

Authors:  A Hamvas; L M Nogee; G B Mallory; T L Spray; C B Huddleston; A August; L P Dehner; D E deMello; M Moxley; R Nelson; F S Cole; H R Colten
Journal:  J Pediatr       Date:  1997-02       Impact factor: 4.406

Review 3.  Pulmonary alveolar proteinosis.

Authors:  J M Davidson; W M Macleod
Journal:  Br J Dis Chest       Date:  1969-01

4.  Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes.

Authors:  Frank Brasch; Anja Ten Brinke; Georg Johnen; Matthias Ochs; Nadine Kapp; Klaus M Müller; Michael F Beers; Heinz Fehrenbach; Joachim Richter; Joseph J Batenburg; Frank Bühling
Journal:  Am J Respir Cell Mol Biol       Date:  2002-06       Impact factor: 6.914

5.  Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression.

Authors:  U Dirksen; R Nishinakamura; P Groneck; U Hattenhorst; L Nogee; R Murray; S Burdach
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis.

Authors:  J F Seymour; J J Presneill; O D Schoch; G H Downie; P E Moore; I R Doyle; J M Vincent; K Nakata; T Kitamura; D Langton; M C Pain; A R Dunn
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

7.  Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs.

Authors:  Frank Brasch; Georg Johnen; Alexandra Winn-Brasch; Susan H Guttentag; Andreas Schmiedl; Nadine Kapp; Yasuhiro Suzuki; Klaus M Müller; Joachim Richter; Samuel Hawgood; Matthias Ochs
Journal:  Am J Respir Cell Mol Biol       Date:  2003-09-11       Impact factor: 6.914

Review 8.  Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies.

Authors:  G Dranoff; R C Mulligan
Journal:  Stem Cells       Date:  1994       Impact factor: 6.277

Review 9.  Pulmonary alveolar proteinosis: experience with eight pediatric cases and a review.

Authors:  B Mahut; C Delacourt; P Scheinmann; J de Blic; T M Mani; J C Fournet; G Bellon
Journal:  Pediatrics       Date:  1996-01       Impact factor: 7.124

10.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

View more
  2 in total

1.  A role for MCP-1/CCR2 in interstitial lung disease in children.

Authors:  Dominik Hartl; Matthias Griese; Thomas Nicolai; Gernot Zissel; Christine Prell; Dietrich Reinhardt; Dolores J Schendel; Susanne Krauss-Etschmann
Journal:  Respir Res       Date:  2005-08-11

Review 2.  [Interstitial pulmonary diseases].

Authors:  F Brasch
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.